| Members |
targetComponentId |
| Budgerigar radio-allergosorbent test |
Budgerigar droppings specific immunoglobulin E antibody measurement |
| Budgerigar radio-allergosorbent test |
Budgerigar feathers specific immunoglobulin E antibody measurement (procedure) |
| Budgerigar radio-allergosorbent test |
Budgerigar droppings specific immunoglobulin E antibody measurement |
| Budgerigar radio-allergosorbent test |
Budgerigar serum proteins specific immunoglobulin E antibody measurement (procedure) |
| Budvicia-art |
Budvicia |
| Buff-throated woodhewer |
Xiphorhynchus guttatus (organism) |
| Buffalo obesity |
Central obesity |
| Buffalo obesity |
Buffalo obesity |
| Building society manager (& [branch]) |
Building society branch manager |
| Building society manager (& [branch]) |
Building society branch manager |
| Building society manager (& [branch]) |
Building society manager |
| Building society manager (& [branch]) |
Building society manager |
| Bulbær konjunktival filtrationspude |
Disorder of filtering bleb (disorder) |
| Bulbær konjunktival filtrationspude |
Functional filtering bleb (finding) |
| Bulbar hemorrhage |
Hemorrhage of medulla oblongata (disorder) |
| Bulbær blødning |
Hemorrhage of medulla oblongata (disorder) |
| Bulky uterus (& [NOS]) or enlarged uterus |
Bulky uterus |
| Bulky uterus (& [NOS]) or enlarged uterus |
Enlarged uterus |
| Bulky uterus (& [NOS]) or enlarged uterus |
Bulky uterus |
| Bulky uterus (& [NOS]) or enlarged uterus |
Enlarged uterus |
| Bulleidia-art |
Bulleidia |
| Bullfinch |
Genus Pyrrhula (organism) |
| Bullfinch |
Genus Loxigilla (organism) |
| Bullfinch |
Melopyrrha nigra (organism) |
| Bullous erythema multiforme |
Stevens-Johnson syndrome is a limited form of toxic epidermal necrolysis with characteristics of destruction and detachment of the skin epithelium and mucous membranes involving less than 10% of the body surface area. The disease can be triggered by a drug allergy and, more rarely, by infections or bone marrow transplantation. In 25 to 30% of cases, the cause is unclear. |
| Bullous erythema multiforme |
Erythema multiforme |
| bumetanid 500 µg/ml injektionsvæske, opløsning, ampul a 4 ml |
Bumetanide 500 microgram/mL solution for injection |
| bumetanid 500 µg + kalium 7,7 mmol tablet med modificeret udløsning |
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet |
| Bungarus candidus |
Bungarus candidus |
| Bunion |
Swelling of first metatarsophalangeal joint of hallux (disorder) |
| Bunion |
Hallux valgus AND bunion |
| Bunion of great toe |
Hallux valgus AND bunion |
| Bunion of great toe |
Swelling of first metatarsophalangeal joint of hallux (disorder) |
| Bunionectomy |
Silver bunionectomy |
| Bunionectomy |
Excision of bunion |
| Bunionectomy with soft tissue correction |
Bunionectomy with soft tissue correction |
| Bunionectomy with soft tissue correction |
McBride operation |
| Bunyavirus |
Family Bunyaviridae (organism) |
| Bunyavirus |
Genus Orthobunyavirus (organism) |
| Buphthalmos |
Buphthalmos (finding) |
| Buphthalmos |
Primary congenital glaucoma (disorder) |
| Buphthalmos |
Primary congenital glaucoma (disorder) |
| Buphthalmos |
Buphthalmos (finding) |
| Buphthalmos NOS |
Primary congenital glaucoma (disorder) |
| Buphthalmos NOS |
Buphthalmos (finding) |
| Buphthalmos with congenital keratoglobus |
Primary congenital glaucoma (disorder) |
| Buphthalmos with congenital keratoglobus |
Buphthalmos (finding) |
| Buphthalmos with congenital keratoglobus |
Congenital keratoglobus |
| Buphthalmos with congenital lens dislocation |
Buphthalmos (finding) |
| Buphthalmos with congenital lens dislocation |
Complete luxation of lens (disorder) |
| Buphthalmos with megalocornea |
Megalocornea |
| Buphthalmos with megalocornea |
Primary congenital glaucoma (disorder) |
| Buphthalmos with megalocornea |
Buphthalmos (finding) |
| Buphthalmos with other eye anomaly |
Buphthalmos (finding) |
| Buphthalmos with other eye anomaly |
Primary congenital glaucoma (disorder) |
| Buphthalmos with other eye anomaly NOS |
Buphthalmos (finding) |
| Buphthalmos with other eye anomaly NOS |
Primary congenital glaucoma (disorder) |
| Buphthalmos, unspecified |
Buphthalmos (finding) |
| Buphthalmos, unspecified |
Primary congenital glaucoma (disorder) |
| Bupivacaine + dextrose |
Product containing bupivacaine (medicinal product) |
| bupivacain 2,5 mg/ml (0,25 %) injektionsvæske, opløsning, ampul a 10 ml |
Bupivacaine hydrochloride 2.5 mg/mL solution for injection |
| bupivacain 5 mg/ml (0,5 %) injektionsvæske, opløsning, ampul a 10 ml |
Product containing precisely bupivacaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| buprenorphin 300 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
Product containing precisely buprenorphine (as buprenorphine hydrochloride) 300 microgram/1 milliliter conventional release solution for injection (clinical drug) |
| buprenorphin 35 µg/time depotplaster |
Buprenorphine 35 microgram/hour prolonged-release transdermal patch |
| Buprenorphine 35micrograms/hour transdermal patch |
Buprenorphine 35 microgram/hour prolonged-release transdermal patch |
| buprenorphin 52,2 µg/time depotplaster |
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Buprenorphine 52.5micrograms/hour transdermal patch |
Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Buprenorphine 70micrograms/hour transdermal patch |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| buprenorphin 70 µg/time depotplaster |
Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| bupropionhydrochlorid 150 mg tablet med modificeret udløsning |
Product containing precisely bupropion hydrochloride 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Bupropion hydrochloride 150mg m/r tablet |
Product containing precisely bupropion hydrochloride 150 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Burkholderia mallei |
Burkholderia mallei |
| Burkholderia-art |
Genus Burkholderia (organism) |
| Burkitts lymfom associeret med aids |
Burkitt lymphoma co-occurrent with human immunodeficiency virus infection (disorder) |
| Burmese fairy bluebird |
Irena puella (organism) |
| Burn - cornea - eye |
Burn of eye proper (disorder) |
| Burn - face &/or head &/or neck |
Head burn (disorder) |
| Burn - face &/or head &/or neck |
Head burn (disorder) |
| Burn - face &/or head &/or neck |
Burn of neck (disorder) |
| Burn - face &/or head &/or neck |
Burn of head AND/OR neck |
| forbrænding eller ætsning af tarmorganer |
Burn of gastrointestinal tract |
| Burn - intestinal organs |
Burn of gastrointestinal tract |
| Burn - larynx &/or trachea &/or lung |
Burn of trachea |
| Burn - larynx &/or trachea &/or lung |
Burn of larynx, trachea and lung |
| Burn - larynx &/or trachea &/or lung |
Burn of larynx, trachea and lung |
| Burn - larynx &/or trachea &/or lung |
Burn of larynx |
| Burn - larynx &/or trachea &/or lung |
Burn of lung |
| Burn - larynx &/or trachea &/or lung |
Burn of lung |
| Burn - leg &/or foot |
Burn of lower limb |
| Burn - leg &/or foot |
Burn of foot |
| Burn - leg &/or foot |
Burn of lower limb |
| Burn - vagina &/or uterus |
Burn of vagina and uterus |
| Burn - vagina &/or uterus |
Burn of vagina |
| Burn - vagina &/or uterus |
Burn of vagina |
| Burn - wrist &/or hand |
Burn of wrist |
| Burn - wrist &/or hand |
Burn of wrist |
| Burn - wrist &/or hand |
Burn of hand |
| Burn - wrist &/or hand |
Burn of hand |
| Burn dressing |
Application of dressing for burn |
| Burn dressing |
Application of dressing for burn |
| forbrændingserytem i ansigt OG/ELLER hoved |
Epidermal burn of face (disorder) |
FHIR